Home / MRVL.V : TSXV

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does MRVL.V make money? Does MRVL.V have pricing power? What's the Earnings Whisper? Will MRVL.V profit more as the business scales? What is MRVL.V's management track record? Is MRVL.V's current price justified?

Marvel Biosciences Corp.

CAD 0.14 +$0.01 (+3.70%)

TSXV · 14 Sep 2026 14:19 UTC

Previous Close

CAD 0.15

Day Range

CAD 0.14CAD 0.15

Year Range

CAD 0.12CAD 0.26

Market Cap

8.82M

AVG Volume

69.82K

Trailing/Forward PE

-5.24/-

PEG ratio

-0.28

Dividend Yield

Next Earnings Date

Primary Exchange

Toronto Stock Exchange Ventures

Net Income (CAD)

MRVL.V Net Income (CAD) by year
Period	Net Income (CAD)
2025	-2.21M
2024	-1.65M
2023	-2.29M
2022	-2.55M
2021	-3.04M

Operating Income (CAD)

MRVL.V Operating Income (CAD) by year
Period	Operating Income (CAD)
2025	-1.25M
2024	-1.27M
2023	-2.24M
2022	-2.54M
2021	670.07K

EBITDA (CAD)

MRVL.V EBITDA (CAD) by year
Period	EBITDA (CAD)
2025	-1.94M
2024	-1.54M
2023	-2.23M
2022	-2.55M
2021	-1.32M

Cash Flows (CAD)

MRVL.V Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2025	-1.15M
2024	-1.18M
2023	-1.33M
2022	-2.19M
2021	-1.37M

EPS (CAD)

MRVL.V EPS (CAD) by year
Period	EPS (CAD)
2025	-0.04
2024	-0.04
2023	-0.06
2022	-0.08
2021	-0.09

Expenses (CAD)

MRVL.V Expenses (CAD) by year
Period	Expenses (CAD)
2025	1.17M
2024	1.18M
2023	2.3M
2022	2.5M
2021	1.32M

Cash & Debt (CAD)

MRVL.V Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2025	128.85K
2024	345.77K
2023	556.62K
2022	593.21K
2021	2.39M

Debt ratios

MRVL.V Debt ratios by year
Period	Debt ratios
2025	-0.26
2024	-0.18

Return on Capital

MRVL.V Return on Capital by year
Period	Return on Capital
2025	55.2%
2024	58.39%
2023	133.21%
2022	-1306.22%
2021	-129.02%

Shares Outstanding

MRVL.V Shares Outstanding by year
Period	Shares Outstanding
2025	52.95M
2024	39.79M
2023	39.79M
2022	37.09M
2021	32.59M

Book Value Per Share (CAD)

MRVL.V Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2025	-0.08
2024	-0.07
2023	-0.04
2022	0.01
2021	0.07

Total Assets (CAD)

MRVL.V Total Assets (CAD) by year
Period	Total Assets (CAD)
2025	326.71K
2024	491.31K
2023	672.39K
2022	913.54K
2021	2.47M

Free Cash Flow Yield

MRVL.V Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-8.43%
Sep 26	-8.43%
Aug 26	-8.16%
Aug 26	-8.43%
Aug 26	-7.44%
Aug 26	-7.67%
Jul 26	-8.43%
Jul 26	-15.89%
Jul 26	-16.95%
Jul 26	-14.95%
Jul 26	-16.4%
Jun 26	-14.95%
Jun 26	-13.04%
Jun 26	-11.82%
Jun 26	-13.04%
May 26	-16.95%
May 26	-15.89%
May 26	-15.89%
May 26	-16.95%
May 26	-15.41%
Apr 26	-11.99%
Apr 26	-11.29%
Apr 26	-13.71%
Apr 26	-10.66%
Mar 26	-11.99%
Mar 26	-12.38%
Mar 26	-13.71%
Mar 26	-13.71%
Feb 26	-14.21%
Feb 26	-15.99%
Feb 26	-12.79%
Feb 26	-13.71%
Jan 26	-14.21%
Jan 26	-15.52%
Jan 26	-15.52%
Jan 26	-15.52%
Jan 26	-16.09%
Dec 25	-15.52%
Dec 25	-14.98%
Dec 25	-14.01%
Dec 25	-13.58%
Nov 25	-14.98%
Nov 25	-12.78%
Nov 25	-12.07%
Nov 25	-12.78%
Oct 25	-9.87%
Oct 25	-10.8%
Oct 25	-11.83%
Oct 25	-11.04%
Oct 25	-10.35%
Sep 25	-9.93%
Sep 25	-9.74%
Sep 25	-9.93%
Sep 25	-9.2%
Aug 25	-8.56%
Aug 25	-12.42%
Aug 25	-11.55%
Aug 25	-13.8%
Aug 25	-14.19%
Jul 25	-14.25%
Jul 25	-12.62%
Jul 25	-12.27%
Jul 25	-13.81%
Jun 25	-14.73%
Jun 25	-15.23%
Jun 25	-17.67%
Jun 25	-24.54%
May 25	-21.04%
May 25	-25.99%
May 25	-25.99%
May 25	-24.54%
May 25	-25.99%
Apr 25	-26.85%
Apr 25	-28.26%
Apr 25	-24.41%
Apr 25	-21.48%
Mar 25	-21.48%
Mar 25	-18.51%
Mar 25	-18.51%
Mar 25	-19.89%
Feb 25	-19.18%
Feb 25	-17.9%
Feb 25	-17.9%
Feb 25	-17.32%
Jan 25	-17.32%
Jan 25	-19.76%
Jan 25	-18.53%
Jan 25	-19.13%
Jan 25	-17.97%
Dec 24	-19.13%
Dec 24	-18.53%
Dec 24	-19.76%
Dec 24	-19.13%
Nov 24	-19.13%
Nov 24	-17.97%
Nov 24	-18.53%
Nov 24	-21.96%
Nov 24	-21.96%
Oct 24	-28.07%
Oct 24	-21.52%

Price to Book

MRVL.V Price to Book by year
Period	Price to Book
Jul 23	213.47
Jul 23	226.82
Jul 23	240.16
Jul 23	226.82
Jun 23	240.16
Jun 23	226.82
Jun 23	240.16
Jun 23	240.16
Jun 23	253.5
May 23	253.5
May 23	240.16
May 23	266.84
May 23	266.84
Apr 23	15.52
Apr 23	16.38
Apr 23	16.38
Apr 23	14.66
Mar 23	16.38
Mar 23	15.52
Mar 23	16.38
Mar 23	18.11
Mar 23	17.24
Feb 23	17.24
Feb 23	17.24
Feb 23	17.24
Feb 23	17.24
Jan 23	18.97
Jan 23	23.71
Jan 23	23.71
Jan 23	21.81
Dec 22	23.71
Dec 22	23.71
Dec 22	27.5
Dec 22	27.5
Dec 22	27.5
Nov 22	27.5
Nov 22	28.45
Nov 22	21.81
Nov 22	18.97
Oct 22	9.77
Oct 22	8.5
Oct 22	8.5
Oct 22	12.75
Sep 22	10.2
Sep 22	6.8
Sep 22	6.8
Sep 22	8.5
Sep 22	9.35
Aug 22	8.07
Aug 22	8.07
Aug 22	8.92
Aug 22	8.5
Jul 22	7.22
Jul 22	3.99
Jul 22	3.99
Jul 22	3.99
Jun 22	3.99
Jun 22	3.57
Jun 22	4.2
Jun 22	4.2
Jun 22	4.2
May 22	4.83
May 22	4.83
May 22	5.25
May 22	4.41
Apr 22	2.38
Apr 22	2.38
Apr 22	2.83
Apr 22	2.65
Apr 22	2.91
Mar 22	2.21
Mar 22	2.47
Mar 22	3.09
Mar 22	3.44
Feb 22	3.44
Feb 22	3.53
Feb 22	3.8
Feb 22	3.53
Jan 22	2.35
Jan 22	2.49
Jan 22	2.77
Jan 22	3.04
Dec 21	3.73
Dec 21	3.6
Dec 21	3.18
Dec 21	3.73
Dec 21	3.94
Nov 21	3.18
Nov 21	3.6
Nov 21	3.87
Nov 21	3.6
Oct 21	3.46
Oct 21	19.28
Oct 21	20.96
Oct 21	16.77
Oct 21	16.77
Sep 21	17.6
Sep 21	19.28
Sep 21	16.77
Sep 21	20.96

No video analysis for this stock yet. Request one from our team.

News: MRVL.V

feeds.newsfilecorp.com · 9 Sep 2026

Marvel Biosciences annonce la prolongation de la date limite de clôture du placement privé

Calgary, Alberta--(Newsfile Corp. - 9 septembre 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) (« Marvel » ou la

feeds.newsfilecorp.com · 1 Sep 2026

Marvel Biosciences Announces Grant of Deferred Share Units

Calgary, Alberta--(Newsfile Corp. - September 1, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology

AI Analysis

Marvel Biosciences Corp.

Video analysis: MRVL.V

News: MRVL.V

Marvel Biosciences annonce la prolongation de la date limite de clôture du placement privé

Marvel Biosciences Announces Grant of Deferred Share Units

Similar companies